[Press Alert] XENOTHERA, Nantes University Hospital and the University of Nantes announce the signature of a consortium agreement within the framework of PSPC-COVID.
November, 2024. The PALT24 project (Polyspecific Antibodies in Lymphoproliferative T cell disorders) targets a critical onco-hematological disease with a notably low prognosis.
